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ABSTRACT
Objective: The aim of the study is an evaluation of toxicity assessment of biosynthesized silver nanoparticles (AgNPs) from Solanum villosum (Mill.) 
using in vitro and in vivo study.
Methods: Biologically synthesized AgNPs are characterized by ultraviolet, scanning electron microscopy, energy dispersive X-ray spectroscopy, X-ray 
diffraction analysis, and its cytotoxicity effect against HepG2 cell lines was performed. Further, toxicity was confirmed by in vivo studies using Wistar 
albino rats. Various hematological, liver function marker enzymes and liver histopathology are investigated.
Results: The cytotoxic effect of S. villosum AgNPs (SV-AgNPs) was also concentration dependent and did not produce any toxicity to tested animals. 
The histopathological evidence is supported to biochemical observations.
Conclusion: So, biologically synthesized AgNPs are toxic only to cancer cells but not in animals were proved by the present study.
Keywords: Solanum villosum silver nanoparticles, HepG2 cell lines, Scanning electron microscopy, Energy dispersive X-ray spectroscopy, X-ray 
diffraction analysis.
INTRODUCTION
The field of nanotechnology is one of the upcoming areas of research 
in the modern field of material science. Nanoparticle shows completely 
new or improved properties, such as size, distribution, and morphology 
of the particles. Novel applications of nanoparticles and nanomaterials 
are emerging rapidly on various fields [1]. Nanocrystalline silver 
particles have been found tremendous applications in the fields 
of high sensitivity biomolecular detection, diagnostics, anticancer, 
therapeutics, catalysis, and microelectronics. However, there is still 
need for economic commercially viable as well as environmentally 
clean synthesis route to synthesize the silver nanoparticles (AgNPs). 
Silver is well known for possessing an inhibitory effect toward many 
bacterial strains and microorganisms commonly present in medical and 
industrial processes [2].
Green synthesis of metal nanoparticles is a growing research 
area because of their potential applications in nanomedicines. 
The synthesis of AgNPs using Solanum villosum leaves and its 
characterization is done using ultraviolet (UV), scanning electron 
microscopy (SEM), energy dispersive X-ray spectroscopy (EDX), 
and X-ray diffraction (XRD) analysis. In vitro cytotoxicity testing 
procedures reduce the use of laboratory animals. Hepatocellular 
carcinoma (HCC) is the fifth most common cancer in the world and 
the third most common cause of cancer death and accounts for 5.6% 
of all cancers [3].
The present study may open up several promising avenues of possible 
research. The S. villosum and related species are widely used as leafy 
herbs and vegetables, as a source of fruit and for various medicinal 
purposes. The S. villosum plant has been used in many ayurvedic 
medicines [4,5]. In spite of known uses in traditional medicines, no 
documental evidence is available on their biosynthesis of AgNPs and 
its activities. Hence, AgNPs of S. villosum are evaluated in a systematic 
manner to provide information for treating and preventing cancer and 
other diseases.
METHODS
Collection of plant material
The whole plant of S. villosum (Mill.) was collected from the Thadagam 
hills, Coimbatore district, southern India. The plant samples were 
identified and authenticated by the Botanical Survey of India (Southern 
part Coimbatore, Tamil Nadu, India). The identification No. BSI/
SRC/5/23/2014-15/Tech/255. Various stages of plant, S. villosum is 
shown in the Fig. 1.
Preparation of aqueous extract of S. villosum leaves
The dried S. villosum leaves powder 10 g was boiled in 100 ml of distilled 
water for 10 minutes. The extract was cooled to room temperature 
filtered through Whatman No. 1 filter paper (Pore size 25 μm). The 
filtrate was further filtered through 0.6 μm sized filters.
Synthesis of AgNPs
The AgNPs were synthesized using a constant volume of the plant 
extract under various experimental conditions. Aqueous solution 
of 1 mM AgNO₃ was prepared and used for the synthesis of AgNPs. 
5 ml of S. villosum aqueous extract is mixed with 95 ml of AgNO₃ for 
the synthesis of AgNPs. The formation of AgNPs is confirmed by color 
change from greenish to reddish brown. The appearance of reddish 
brown color after 3 hrs it indicates the formation of AgNPs.
Separation of AgNPs
The synthesized AgNPs were separated by centrifugation 
(Spectrofuge 7M) at 13,000 rpm for 15 minutes. The process was 
repeated by dispersion of pellets in water, to obtain colored supernatant 
solutions. The sample was then stored at −4°C for further use.
Characterization of AgNPs
UV-vis spectra analysis
The reduction of pure Ag+ ions was monitored by measuring the UV-vis 
spectrum of the reaction medium at 5 10-12 hrs. UV-Vis spectral analysis 
was done using UV-vis spectrophotometer UV- 2450 (Shimadzu).
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SEM
SEM analysis was done using Hitachi S-4500 SEM machine. Thin films of 
the sample were prepared on a carbon coated copper grid by just dropping 
a very small amount of the sample on the grid, extra solution was removed 
using a blotting paper and then the films on the SEM grid were allowed to 
dry by putting (placing) them under a mercury lamp for 5 minutes.
EDX
Energy dispersive X-ray analysis, the aqueous extract of S. villosum was 
dried and drop coated onto carbon film and performed on JEOL-MODEL 
6390 SEM instrument equipped with a Thermo EDX attachments.
XRD analysis
The AgNPs solution obtained was purified by repeated centrifugation at 
5000 rpm for 30 minutes followed by redispersion of the pellet of AgNPs 
into 10 ml of deionized water. After freeze drying of the purified silver 
particles, the structure and composition were analyzed by XRD and 
SEM. The dried mixture of AgNPs was collected for the determination 
of the formation of AgNPs by an X’ Pert Pro X-ray diffractometer (PAN 
analytical BV, The Netherlands) operated at a voltage of 40 kV and a 
current of 30 mA with Cu K α radiation in a configuration.
In vitro cytotoxic effect of S. villosum AgNPs (SV-AgNPs) on HepG2 
cell lines [6,7]
The human liver cancer cell line (HepG2) was obtained from the 
national center for cell science, Pune, and grown in eagles minimum 
essential medium containing 10% fetal bovine serum (FBS). All cells 
were maintained at 37°C, 5% CO2, 95% air, and 100% relative humidity. 
Maintenance cultures were passaged weekly, and the culture medium 
was changed twice a week.
Cell treatment procedure
The monolayer cells were detached with trypsin-ethylene diamine 
tetra acetic acid to make single cell suspensions, and viable cells were 
counted by trypan blue exclusion assay using a hemocytometer. The cell 
suspension was diluted with medium containing 5% FBS to give final 
density of 1×105 cells/ml. 100 µl per well of cell suspension was seeded 
into 96-well plates at plating density of 10,000 cells/well and incubated 
to allow for cell attachment at 37°C, 5% CO2, 95% air, and 100% relative 
humidity. After 24 hrs, the cells were treated with serial concentrations 
of the test samples. They were initially dispersed in phosphate buffered 
saline and diluted to twice the desired final maximum test concentration 
with serum-free medium. Additional four, 2-fold serial dilutions were 
made to provide a total of five sample concentrations. Aliquots of 100 µl 
of these different sample dilutions were added to the appropriate wells 
already containing 100 µl of medium, resulted the required final sample 
concentrations. Following drug addiction, the plates were incubated 
for an additional 48 hrs at 37°C, 5% CO2, 95% air, and 100% relative 
humidity. The medium containing without samples were served as 
control and triplicate were maintained for all concentrations.
% Cell inhibition=100−Abs (sample)/Abs (control)×100.
Nonlinear regression graph was plotted between % cell inhibition 
and log concentration, and inhibitory concentration at 50% (IC50) was 
determined using GraphPad Prism software.
In vivo toxicity assessment of SV-AgNPs
Experimental animals
Healthy adult male Wistar albino rats weighing about 150-200 g were 
obtained from the small animal breeding center, Kerala Agricultural 
University, Mannuthy, Thrissur, Kerala, India. They were housed in 
polypropylene cages under the standard laboratory condition (25±2°C, 
humidity 60-70%, 12 hrs light/dark cycles). The animals were fed with 
commercial rat pellet diet (Sriram animal foods, Coimbatore, Tamil Nadu, 
India.) and water was provided ad libitum. The rats were acclimatized 
to laboratory conditions for 1 week before the commencement of the 
experiment. The animal care and handling were done according to 
the regulations of Council Directive CPCSEA no: 659/02/a about Good 
Laboratory Practice on animal experimentation. All animal experiments 
were performed in the laboratory according to the ethical guidelines 
suggested by the Institutional Animal Ethics Committee (IAEC).
Experimental design
To find out the toxicity effect of SV-AgNPs on male Wistar albino rats 
were carried out. In AgNPs, the IC50 determined by MTT assay was used 
for fixing of different doses. After the adaptation period, the animals 
were divided into four groups with six animals in each group.
• Group I: Control.
• Group II: Rats fed with SV-AgNPs 100 µg/kg body weight for 28 days.
• Group III: Rats fed with SV-AgNPs 200 µg/kg body weight for 28 days.
• Group IV: Rats fed with SV-AgNPs 300 µg/kg body weight for 28 days.
During the dosing periods, all the animals were observed daily for 
clinical signs and mortality patterns once before dosing, immediately 
after dosing and up to 4 hrs [8]. The body weight of each rat was 
assessed using a sensitive balance during the acclimatization period.
Hematological parameters
The hematological parameters such as hemoglobin packed cell volume, 
red blood cell, white blood cell, and platelet counts were assayed. The 
whole blood sample was analyzed for the changes in the blood cells 
using SYSMEX Xs–800 i (5 parts) automatic hematology analyzer.
Biochemical analysis
After the experimental regimen, the animals were sacrificed by 
cervical dislocation under mild chloroform anesthesia. The blood 
was collected in the centrifuge tubes, and serum was separated by 
centrifugation 2000 rpm for 20 minutes. The serum was used for the 
biochemical estimations such as aspartate transaminase (AST), alanine 
transaminase (ALT) [9], alkaline phosphatases (ALP) [10], and total 
protein [11] were assayed using various standard methods.
Histopathological studies
In the histopathological examination, the liver tissues were fixed in 
10% formalin. The sections were cut into 3-5 μm using microtome 
and processed for staining. Pathological changes in liver tissue were 
examined under light microscope [12].
Statistical analysis
Results were expressed as mean±standard deviation of six animals in 
each group. Statistical significance (p<0.05) was determined by one-
way analysis of variance and post-hoc least significant difference test 
using SPSS 17 version.
RESULTS AND DISCUSSION
The biosynthesized AgNPs have been used for various drug delivery 
and drug carrier systems. AgNPs can be used for both active and passive 
targeting of drugs. The AgNP carrying small drug molecules or large 
biomolecules such as proteins, DNA, or RNA. Efficient release of these 
therapeutic agents to a target site for effective therapy.
In the present research work, biosynthesis of AgNPs from silver nitrate 
is one of the most widely used methods in the field of nanotechnology. 
During the biosynthesis, using the plant extract, the color of the 
Fig. 1: Solanum villosum (Mill.) plant
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reaction medium changed rapidly from light greenish yellow to brown 
(Fig. 2a and b) due to surface plasmon resonance. This occurs due to the 
collective oscillations of the conduction electrons confined to metallic 
nanoparticles. The same mechanism was reported in ethanolic extract 
of leaves of Pisonia grandis [13]. It is well known that AgNPs exhibit a 
yellowish-brown color in aqueous solution due to excitation of surface 
plasmon vibrations in AgNPs. The approach employed in the production 
of these materials (AgNPs) is low cost and ecofriendly [14].
The major advantage of using plant extracts for the synthesis of AgNPs 
is that they are easily available, safe, and nontoxic, in most cases, 
have a broad variety of metabolites that can aid in the reduction of 
silver ions and are quicker than microbes in the synthesis. The main 
mechanism considered for the process is a plant-assisted reduction due 
to phytochemicals. The main phytochemicals involved are terpenoids, 
flavones, ketones, aldehydes, amides, and carboxylic acids [15].
The AgNPs were characterized by UV-Vis spectroscopy, one of the most 
widely used techniques and to confirm AgNPs formation by showing 
the plasmon resonance. The absorption spectrum of the AgNPs depicts 
in Fig. 3. The surface plasmon absorption band with a maximum of 
200-800 nm, indicating the presence of AgNPs.
SEM has provided further insight into the morphological details of the 
synthesized AgNPs. SEM micrographs of the synthesized AgNPs using 
the aqueous extract of leaves of S. villosum fabricated on a glass substrate 
are shown in Fig. 4. The synthesized AgNPs were well dispersed without 
aggregation, possessing spherical shapes are confirmed by SEM.
In addition, elemental analysis of the synthesized AgNPs is further 
confirmed by EDX spectra with the absorption peak in the range of 3-4 
keV (Fig. 5). This result is in accordance with the study of Jain et al. [16], 
who reported that the presence of optical absorption peak in the range 
of 3-4 keV is typical for metallic silver nanocrystallites. While weaker 
peaks like C, O2 and Cl are likely due to X-ray emission from proteins/
sugars may be present in the S. villosum leaf extract.
In this, XRD pattern (Fig. 6) showed the conformation of the existence 
of peaks belonging to AgNPs in the sample. The Braggs reflections were 
observed in XRD pattern at around 2Ө=28°, 33°. Hence, the XRD pattern 
thus clearly illustrated that the AgNPs formed in this present synthesis. 
Peak obtained at around 33°indicated that the prepared samples were 
crystalline in nature. The crystalline size (D) was calculated using the 
Scherer’s Debye formula from the full-width half maximum (FWHM).
D=KD/β Cos Ө
2 Ө=1.47897/β Cos Ө 33°
  =1.47897/0.8386=17.63 nm.
2 Ө=1.47897/β Cos Ө 28°
  =1.47897/0.8829=16.75 nm
Where, KD constant=1.47897×10−10
Where, D is the average crystallite domain size perpendicular to the 
reflecting planes. λ is the X-ray wavelength. β is the full width at half 
Fig. 3: Ultraviolet-visible spectra of Solanum villosum aqueous 
leaf extract reduction of silver nanoparticles
Fig. 4: Scanning electron microscopy micrographs for synthesized 
silver nanoparticles from aqueous leaf extract of Solanum villosum
Fig. 5: Energy dispersive X-ray spectrum analysis for biosynthesized 
silver nanoparticles from aqueous leaf extract of Solanum villosum
Fig. 2: (a) Solanum villosum aqueous leaf extract; (b) Color 
changes after adding silver nitrate reaction time of 10-12 hrs
ba
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maximum and θ is the diffraction angle. The crystalline size was found 
to be around 17.63 nm. AgNPs were synthesized by various plant 
materials as capping agents such as papaya [17] and neem [18].
In vitro cytotoxicity activity of SV-AgNPs
In this present research work, we have employed a dose-dependent 
approach to evaluate the toxicity of the biosynthesized AgNPs against 
the human HCC (HepG2) cell line. Evaluation of cytotoxicity in liver 
HepG2 cells by SV-AgNPs was performed using MTT assay (viability 
assay). HepG2 cell line was previously used for various anticancer 
studies. SV-AgNPs (1.88-30 µg/ml) in a dose-dependent manner as seen 
in the MTT assay. We observed AgNPs treatment (24 hrs incubation) 
significantly decreased the percentage of cell viability in HepG2 cells.
The proliferation of HepG2 cell was significantly inhibited by SV-AgNPs. 
Fig. 7 and Table 1 shows the changes in the percentage of cell 
viability treated with SV-AgNPs (1.88, 3.75, 7.5, 15, and 30 µg/ml) in 
HepG2 cells. There was 100% cell death at 30 µg/ml concentration was 
observed. The IC50 was fixed as 8.34 µg/ml. AgNPs mainly react with 
cancer cells, it is selectively involved in disruption of the mitochondrial 
respiratory chain and leading to the production of ROS and interruption 
of ATP synthesis, which, in turn, cause DNA damage. Mainly, the plant 
S. villosum contains the phytochemicals and antioxidants exhibited the 
synergistic effect against the cancer cells. The synthesized AgNPs cause 
cell damage with unique morphological and biochemical hallmarks. 
AgNPs from plant extract can interfere with the respiratory chain at 
the cytochromes and can interact with the electron transport chain 
to activate the intrinsic signaling pathway to cell death through the 
activation of downstream processing.
The cytotoxicity of these nanoparticles depends on their shape, size, 
surface chemistry, etc., as spherical AgNPs and microparticles are 
almost nontoxic to human alveolar epithelial cells [8]. AgNPs seemed to 
be a defense mechanism of protection from the highly reactive behavior 
of silver ions (Ag+) to the cells. The incoming silver ions from the 
aqueous solution into the cells are converted to reduced state (Ag0). The 
synthesis of nanoparticles by this reaction in cells is attributed to the 
presence of an enzyme called nitrate reductase. The enzyme is found to 
be present in both aerobes and anaerobes [19].
Toxicity assessment SV-AgNPs - in vivo study
Body weight and mortality changes
During the treatment of SV-AgNPs, all the animals were observed 
daily for clinical signs and mortality patterns. After administration 
of different doses from 100 µg, 200 µg, and 300 µg/kg body weight, 
no clinical signs, mortality, and body weight changes of the rats. It is 
indicating the nontoxic effect of SV-AgNPs in minimum safety doses 
(Table 2).
Hematological and biochemical assays
In the repeated dose toxicity studies, administration of aqueous extract of 
SV-AgNPs in various experimental groups is carried out. All the groups did 
not produce any significant changes (p<0.05) in hematological parameters 
and biochemical parameters are showed in the Tables 3 and 4. There were 
no harmful changes found in the level of AST, ALT, ALP, total protein in 
serum and hematological parameters in blood of treated groups (II, III, 
and IV) when compared with control (Group I). SV-AgNPs did not affect 
liver enzymes and blood cells, and the lack of significant alterations is a 
good indicator of liver functions and hematopoietic mechanism. Hence, it 
is clearly indicated that SV-AgNPs are nontoxic to normal rats.
Lovric et al. reported that after absorption of nanosilver from the 
gastrointestinal tract, entered to blood systemic circulation, therefore, 
this particle can, potentially, interact with different metabolites such 
as: Plasma proteins, coagulation factors, platelets, red and white 
blood cells. The smaller diameters of the nanoparticles are the more 
its influence and interact to cells and its intracellular mechanisms will 
increase [20].
Fig. 6: X-ray diffraction spectrum analysis for synthesized silver 
nanoparticles from aqueous leaf extract of Solanum villosum Table 1: Effect of SV-AgNPs on HepG2 cell line (% inhibition)






SV-AgNPs: Solanum villosum silver nanoparticles
Fig. 7: In vitro cytotoxic activity of the biosynthesized Solanum 
villosum silver nanoparticles (SV-AgNPs) against HepG2 cell line. 
(a) Untreated HepG2 cell lines, (b) SV-AgNPs - 1.88 µg/ml,  
(c) SV-AgNPs - 3.75 µg/ml, (d) SV-AgNPs - 7.5 µg/ml  






Table 2: Body weight of the rats before and after 28 days of 
treatment with SV-AgNps
Groups Body weight (grams)
Before treatment After treatment
Group I 210.00±5.47 219.00±3.74
Group II 208.33±6.83ns 217.33±6.02ns
Group III 209.17±4.91ns 218.00±4.19ns
Group IV 211.67±2.58ns 220.33±2.33ns
Values are expressed as mean±SD of six animals in each group. Statistical 
comparison: Group I versus Groups II, III, and IV. *Significant at 5% (p<0.05), 
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Histopathological investigations
All the control and experimental animals showed the normal architecture 
(Fig. 8) of the liver with central vein and cords of hepatocytes radiating 
from the central vein indicating the hepatoprotective activity. There was 
no cellular injury which indicates that the SV-AgNPs have no side effect 
at all the doses tested. The evaluation of histopathological changes in 
organs remains a cornerstone in safety assessment of medicines [21].
AgNPs synthesized from medicinal plant S. villosum and evaluated 
toxicity for HepG2 cell lines. The AgNPs significantly decreased the cell 
viability of HepG2 cells but did not cause any changes in the normal 
healthy rats. Nanoparticles of larger size have proven to be toxic to 
the cells. Larger size nanoparticles also do not bind with the specific 
receptors. The smaller size (5-20 nm) of the nanoparticle can easily 
interact with cancer cells cause damage. This particle size range has 
proven to be less toxic to the cells and also exhibit higher binding affinity 
toward the receptors. Similar results have been obtained when the 
particles were checked for interaction with HIV-1 [22]. Another reason, 
binding of AgNPs only with cancer cells but not the other body cells. 
One possible reason could be due to morphological and biochemical 
reaction differences between cancer cells and the other body cells.
The previous study reported that nanoparticle has difference in the 
curvature of the different-shaped nanoparticles. For example, the 
rod-shaped nanoparticles can have a larger contact area with the 
cell membrane receptors than the spherical nanoparticles when the 
longitudinal axis of the rods interacts with the receptors. The cancer 
cells are different in pore size when compared to the other normal cells 
and so a size controlled targeting of AgNPs can prove effective in the 
case of cancer treatment [23].
Current cancer treatments include surgical intervention, radiation and 
chemotherapeutic drugs, which often also kill healthy cells and cause 
toxicity to the patient [24]. The smaller size particles are attributed 
to the stability, catalytic activity, and enhanced adherence to the cells. 
Previous reports suggest that the increase in the concentration of 
AgNPs has resulted in the increase in cell death [25,26]. The effects of 
AgNPs on size-dependent toxicity with various concentrations already 
explained earlier [27].
CONCLUSION
The biological method of synthesis of AgNPs from S. villosum has 
proved to be an ecofriently method than the chemical methods. The 
physical and chemical method involves use of hazardous chemicals 
and highly expensive approaches. The role of AgNPs is an anticancer 
agent in the field of medicine. The use of nanoparticles revealed that 
decrease the use of expensive drugs for cancer treatment. So, the use 
of AgNPs for cancer treatment is the novel and effective approach in 
the field of cancer biology. In conclusion, SV-AgNPs have anticancerous 
activity; it enhances the apoptotic property. Further studies on the 
mechanisms of AgNPs and the new drug discovery for synthesized 
AgNPs of the S. villosum for medical and other industrial application. 
However, further in vivo studies are needed to fully characterize the 
antiproliferative potential of the biosynthesized AgNPs against HCC.
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